Literature DB >> 23740102

Profiles of drug users in Switzerland and effects of early-onset intensive use of alcohol, tobacco and cannabis on other illicit drug use.

Stéphanie Baggio1, Joseph Studer, Meichun Mohler-Kuo, Jean-Bernard Daeppen, Gerhard Gmel.   

Abstract

QUESTIONS UNDER STUDY / PRINCIPLES: The main aim of this study was to investigate profiles of drug users, with a particular focus on illicit drugs other than cannabis, and to explore the effect of early-onset intensive use (drunkenness, daily smoking, high on cannabis) on profiles of illicit drug use.
METHODS: Baseline data from a representative sample of 5,831 young Swiss men in the ongoing Cohort Study on Substance Use Risk Factors were used. Substance use (alcohol, tobacco, cannabis and 15 types of other illicit drug) and age of onset of intensive use were assessed. The Item Response Theory (IRT) and prevalence rates at different ages of onset were used to reveal different profiles of illicit drug use.
RESULTS: In addition to cannabis, there were two profiles of other illicit drug use: (a) "softer" drug users (uppers, hallucinogens and inhaled drugs), among which ecstasy had the highest discriminatory potential (IRT slope = 4.68, standard error (SE) = 0.48; p <0.001); and (b) "harder" drug users (heroin, ketamine, gamma-hydroxybutyrate/gamma-hydroxylactone, research chemicals, crystal meth and spice), among which ketamine had the highest discriminatory potential (slope = 4.05; SE = 0.63; p <0.001). Onset of intensive use at the age of 12 years or younger also discriminated between these two profiles.
CONCLUSION: Both the IRT model and the effect of onset of intensive use enabled two groups of illicit drugs to be identified. In particular, very early onset (at 12 years or younger) intensive use of any substance was a marker for later use of the second group of drugs.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23740102     DOI: 10.4414/smw.2013.13805

Source DB:  PubMed          Journal:  Swiss Med Wkly        ISSN: 0036-7672            Impact factor:   2.193


  7 in total

1.  Pharmacokinetics and subjective effects of a novel oral LSD formulation in healthy subjects.

Authors:  Friederike Holze; Urs Duthaler; Patrick Vizeli; Felix Müller; Stefan Borgwardt; Matthias E Liechti
Journal:  Br J Clin Pharmacol       Date:  2019-04-29       Impact factor: 4.335

2.  Adult attention-deficit/hyperactivity disorder and its association with substance use and substance use disorders in young men.

Authors:  N Estévez; M Dey; D Eich-Höchli; S Foster; G Gmel; M Mohler-Kuo
Journal:  Epidemiol Psychiatr Sci       Date:  2015-05-20       Impact factor: 6.892

3.  Progression to regular heroin use: examination of patterns, predictors, and consequences.

Authors:  Eric A Woodcock; Leslie H Lundahl; Jonathan J K Stoltman; Mark K Greenwald
Journal:  Addict Behav       Date:  2015-02-26       Impact factor: 3.913

4.  Comparing the potential causal influence of two indicators of early alcohol use on later alcohol use disorder symptoms.

Authors:  Christal N Davis; Wendy S Slutske; Thomas M Piasecki; Nicholas G Martin; Michael T Lynskey
Journal:  J Abnorm Psychol       Date:  2019-10-10

5.  Predictors of onset of cannabis and other drug use in male young adults: results from a longitudinal study.

Authors:  Severin Haug; Carla López Núñez; Julia Becker; Gerhard Gmel; Michael P Schaub
Journal:  BMC Public Health       Date:  2014-11-22       Impact factor: 3.295

Review 6.  Peripheral polyneuropathy and acute psychosis from chronic nitrous oxide poisoning: A case report with literature review.

Authors:  Radhika Sood; Thibault Parent
Journal:  Medicine (Baltimore)       Date:  2022-08-05       Impact factor: 1.817

7.  Risk factors and consequences of traumatic brain injury in a Swiss male population cohort.

Authors:  Valentin Petre Matei; Alina Elena Rosca; Alexandru Neculai Pavel; Radu Mihai Paun; Gerhard Gmel; Jean-Bernard Daeppen; Joseph Studer
Journal:  BMJ Open       Date:  2022-07-21       Impact factor: 3.006

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.